Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Shimizu

Showing results (71-80 of 219) with videos related to

Pageof 22
Sort By:
Neuromuscular Disorders : NMD|May 23, 2016
Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein geneShiro Matsubara, Toshio Shimizu, Takashi Komori, et al.
Frontiers in Neurology|November 29, 2023
Case report: MRI-negative myelitis following COVID-19 with SEP abnormalities: a case series and literature reviewKentaro Kawama, Rui Shimazaki, Yoko Sunami, et al.
Acta Neurologica Belgica|August 5, 2023
High doses of opioids usage for amyotrophic lateral sclerosis patients with non-invasive ventilationRyo Morishima, Toshio Shimizu, Hideki Kimura, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 30, 2022
The difference in the diaphragmatic physiological measures between inspiratory and expiratory phases in ALSRyo Morishima, Toshio Shimizu, Yukie Ishizaka, et al.
International Journal of Clinical Oncology|June 15, 2007
Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experienceToshio Shimizu, Taroh Satoh, Kenji Tamura, et al.
Japanese Journal of Clinical Oncology|March 6, 2009
Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumorsNoboru Yamamoto, Yasuhide Yamada, Yutaka Fujiwara, et al.
Journal of Computer Assisted Tomography|December 19, 2002
Automatic brain tissue extraction method using erosion-dilation treatment (BREED) from three-dimensional magnetic resonance imaging T1-weighted dataNaoki Miura, Akito Taneda, Kazuhito Shida, et al.
Nucleic Acids Research|June 25, 2004
ConPred II: a consensus prediction method for obtaining transmembrane topology models with high reliabilityMasafumi Arai, Hironori Mitsuke, Masami Ikeda, et al.
Brain : a Journal of Neurology|July 24, 2002
Motor cortical disinhibition in the unaffected hemisphere after unilateral cortical strokeToshio Shimizu, Akiko Hosaki, Taro Hino, et al.
ESMO Open|April 12, 2020
Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trialsYutaka Fujiwara, Aya Kuchiba, Takafumi Koyama, et al.
Pageof 22

Showing results (71-80 of 219) with videos related to

Sort By:
Pageof 22
Neuromuscular Disorders : NMD|May 23, 2016
Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein geneShiro Matsubara, Toshio Shimizu, Takashi Komori, et al.
Frontiers in Neurology|November 29, 2023
Case report: MRI-negative myelitis following COVID-19 with SEP abnormalities: a case series and literature reviewKentaro Kawama, Rui Shimazaki, Yoko Sunami, et al.
Acta Neurologica Belgica|August 5, 2023
High doses of opioids usage for amyotrophic lateral sclerosis patients with non-invasive ventilationRyo Morishima, Toshio Shimizu, Hideki Kimura, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 30, 2022
The difference in the diaphragmatic physiological measures between inspiratory and expiratory phases in ALSRyo Morishima, Toshio Shimizu, Yukie Ishizaka, et al.
International Journal of Clinical Oncology|June 15, 2007
Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experienceToshio Shimizu, Taroh Satoh, Kenji Tamura, et al.
Japanese Journal of Clinical Oncology|March 6, 2009
Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumorsNoboru Yamamoto, Yasuhide Yamada, Yutaka Fujiwara, et al.
Journal of Computer Assisted Tomography|December 19, 2002
Automatic brain tissue extraction method using erosion-dilation treatment (BREED) from three-dimensional magnetic resonance imaging T1-weighted dataNaoki Miura, Akito Taneda, Kazuhito Shida, et al.
Nucleic Acids Research|June 25, 2004
ConPred II: a consensus prediction method for obtaining transmembrane topology models with high reliabilityMasafumi Arai, Hironori Mitsuke, Masami Ikeda, et al.
Brain : a Journal of Neurology|July 24, 2002
Motor cortical disinhibition in the unaffected hemisphere after unilateral cortical strokeToshio Shimizu, Akiko Hosaki, Taro Hino, et al.
ESMO Open|April 12, 2020
Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trialsYutaka Fujiwara, Aya Kuchiba, Takafumi Koyama, et al.
Pageof 22